高级检索

TCIC-001用于结肠镜前肠道准备的有效性和耐受性:一项探索性随机对照临床试验

Evaluation of efficacy and tolerability of TCIC-001 for bowel preparation prior to colonoscopy: an exploratory randomized controlled clinical trial

  • 摘要:
    目的 比较新型清肠剂TCIC-001与传统聚乙二醇(polyethylene glycol,PEG)电解质散方案在结肠镜检查前肠道准备中的有效性和耐受性。
    方法 前瞻性纳入2021年7月至2022年7月复旦大学附属中山医院拟行结肠镜检查的62例患者,随机分为2组。试验组(TCIC-001组,n=31)口服TCIC-001(分阶段饮水,总入液量1 500 mL),对照组(PEG组,n=31)口服PEG(分4次服药,总入液量3 000 mL)。主要终点指标为波士顿评分评估的肠道清洁质量,次要终点指标包括服药依从性、服药时长、排便次数、排便时长、不良事件发生率(电解质紊乱)等。
    结果 两组受试者性别、年龄及排便次数差异无统计学意义(P>0.05)。有效性方面,两组受试者各肠段波士顿评分和总分差异均无统计学意义(P>0.05),肠道准备良好率均为93.55%。耐受性方面,TCIC-001组受试者服药时长显著短于PEG组(48.8±25.9)min vs(82.8±28.4)min,P<0.001,首次排便早于服药完成的发生率明显低于PEG组(9.68% vs 41.94%,P=0.004)。安全性方面,TCIC-001组和PEG组氯离子紊乱发生率(0 vs 9.68%)及钙离子紊乱发生率(3.23% vs 6.45%)差异均无统计学意义。未观察到其他不良事件。
    结论 TCIC-001在维持与PEG相当的肠道清洁效果基础上,显著缩短服药时长并提高耐受性,且安全性良好。

     

    Abstract:
    Objective To compare the efficacy and tolerability of the novel bowel-cleansing agent TCIC-001 and the traditional polyethylene glycol (PEG) regimen for bowel preparation prior to colonoscopy.
    Methods A total of 62 patients scheduled for colonoscopy at Zhongshan Hospital, Fudan University, between July 2021 and July 2022 were prospectively selected and randomized divided into 2 groups. The experimental group (TCIC-001 group, n=31) received TCIC-001 (drinked in 2 stages, total fluid intake 1 500 mL), while the control group (PEG group, n=31) received PEG electrolyte powder (administered in 4 doses, total fluid intake 3 000 mL). The primary endpoint was bowel cleanliness assessed by the Boston Bowel Preparation Scale (BBPS). Secondary endpoints included medication compliance, duration of medication completion, defecation frequency, duration of defecation, and adverse events (such as electrolyte disturbances).
    Results No significant differences were observed in sex, age, or defecation frequency between the two groups (P>0.05). For efficacy, both groups achieved equivalent bowel cleanliness, with a “good preparation” rate of 93.55% and comparable BBPS score of each intestinal segment and total scores (P>0.05). For tolerability, the TCIC-001 group exhibited significantly shorter medication completion time (48.8±25.9 min vs 82.8±28.4 min, P<0.001) and a lower rate of first defecation before completing medication (9.68% vs 41.94%, P=0.004) than the PEG group. Regarding safety, no significant differences were observed between the TCIC-001 group and the PEG group in incidences of chloride disturbances (0% vs 9.68%) and calcium disturbances (3.23% vs 6.45%). No other adverse events were observed.
    Conclusions TCIC-001 demonstrated comparable bowel-cleansing efficacy to PEG while significantly improving tolerability (reduced medication time and lower risk of premature defecation) and maintaining favorable safety.

     

/

返回文章
返回